NAD+ Injections Now Available via Telehealth for Cellular Health Support
NAD+ injections are now available through telehealth services, offering a prescription-based approach to cellular health. The treatment, which involves a coenzyme linked to energy production and DNA repair, is provided under medical supervision with individualised dosing.
Direct Meds operates as a telehealth platform connecting patients with licensed providers for NAD+ injections. These compounded medications are administered subcutaneously and require an evaluation by a healthcare professional. Dosage is determined by the clinician based on personal health factors, not by the patient.
NAD+ plays a role in cellular energy and DNA repair, with ongoing research exploring its effects on cognition and overall cell function. While injections are generally well tolerated, suitability and potential side effects are assessed individually. Unlike over-the-counter supplements, injections follow a stricter medical process, though outcomes are not guaranteed. The service follows a monthly pricing model covering provider reviews, pharmacy compounding, supplies, and shipping. Pricing and availability may change over time. NAD+ peptides sold as 'research chemicals' remain unapproved for human use and lack the same regulatory oversight as prescription treatments. For inquiries, consumers can contact Direct Meds by phone at (888) 696-7176 or email at [email protected]. No single company is currently identified as offering a combined telehealth service for NAD+, GLP-1 medications, and other preparations.
NAD+ injections provide a medically supervised option for those exploring cellular health support. The treatment requires professional evaluation, with dosing and suitability determined on a case-by-case basis. Patients interested in the therapy must consult a licensed provider through platforms like Direct Meds.
